Wenbiao Ren

986 total citations · 1 hit paper
21 papers, 588 citations indexed

About

Wenbiao Ren is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Wenbiao Ren has authored 21 papers receiving a total of 588 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Surgery, 10 papers in Pulmonary and Respiratory Medicine and 9 papers in Molecular Biology. Recurrent topics in Wenbiao Ren's work include Bladder and Urothelial Cancer Treatments (10 papers), Renal cell carcinoma treatment (5 papers) and Ferroptosis and cancer prognosis (5 papers). Wenbiao Ren is often cited by papers focused on Bladder and Urothelial Cancer Treatments (10 papers), Renal cell carcinoma treatment (5 papers) and Ferroptosis and cancer prognosis (5 papers). Wenbiao Ren collaborates with scholars based in China, United States and Germany. Wenbiao Ren's co-authors include Xiongbing Zu, Jiao Hu, Jinbo Chen, Huihuang Li, Belaydi Othmane, Anze Yu, Guanghui Gong, Peihua Liu, Minfeng Chen and Dongxu Qiu and has published in prestigious journals such as Frontiers in Immunology, Medicine and BMC Medicine.

In The Last Decade

Wenbiao Ren

21 papers receiving 586 citations

Hit Papers

Siglec15 shapes a non-inflamed tumor microenvironment and... 2021 2026 2022 2024 2021 50 100 150 200 250

Peers

Wenbiao Ren
Dennis Peters Netherlands
Joe Chin Canada
Adam G. Baseman United States
Kanagasabai Sahadevan United Kingdom
Meike Adam Germany
Jonathan Huang United States
Philip Dahm United States
Wenbiao Ren
Citations per year, relative to Wenbiao Ren Wenbiao Ren (= 1×) peers Maria Del Carmen Rodriguez Peña

Countries citing papers authored by Wenbiao Ren

Since Specialization
Citations

This map shows the geographic impact of Wenbiao Ren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenbiao Ren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenbiao Ren more than expected).

Fields of papers citing papers by Wenbiao Ren

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wenbiao Ren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenbiao Ren. The network helps show where Wenbiao Ren may publish in the future.

Co-authorship network of co-authors of Wenbiao Ren

This figure shows the co-authorship network connecting the top 25 collaborators of Wenbiao Ren. A scholar is included among the top collaborators of Wenbiao Ren based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wenbiao Ren. Wenbiao Ren is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ren, Wenbiao, et al.. (2025). Causal Associations Between the Presence of Prostate Cancer or Testosterone Levels and Bladder Cancer Risk: A Mendelian Randomization Study. Clinical Genitourinary Cancer. 23(3). 102334–102334. 1 indexed citations
2.
Hu, Jiao, Belaydi Othmane, Anze Yu, et al.. (2021). 5mC regulator-mediated molecular subtypes depict the hallmarks of the tumor microenvironment and guide precision medicine in bladder cancer. BMC Medicine. 19(1). 289–289. 52 indexed citations
3.
Yi, Zhenglin, Zhenyu Ou, Xi Guo, et al.. (2021). Recurrence factors in patients with Keratinizing squamous metaplasia of the bladder after surgical management: a single-center retrospective study. Translational Andrology and Urology. 10(2). 734–740. 3 indexed citations
4.
Quan, Chao, Belaydi Othmane, Jiao Hu, et al.. (2021). N6-Methyladenosine in Cancer Immunotherapy: An Undervalued Therapeutic Target. Frontiers in Immunology. 12. 697026–697026. 20 indexed citations
5.
Zhang, Chunyu, Jiao Hu, Huihuang Li, et al.. (2021). Emerging Biomarkers for Predicting Bladder Cancer Lymph Node Metastasis. Frontiers in Oncology. 11. 648968–648968. 15 indexed citations
6.
Hu, Jiao, Anze Yu, Belaydi Othmane, et al.. (2021). Siglec15 shapes a non-inflamed tumor microenvironment and predicts the molecular subtype in bladder cancer. Theranostics. 11(7). 3089–3108. 250 indexed citations breakdown →
7.
Ren, Wenbiao, Jiao Hu, Huihuang Li, et al.. (2021). miR-616-5p Promotes Invasion and Migration of Bladder Cancer via Downregulating NR2C2 Expression. Frontiers in Oncology. 11. 762946–762946. 12 indexed citations
8.
Qiu, Dongxu, Junwen M. Hu, Jiao Hu, et al.. (2021). PMEPA1 Is a Prognostic Biomarker That Correlates With Cell Malignancy and the Tumor Microenvironment in Bladder Cancer. Frontiers in Immunology. 12. 705086–705086. 16 indexed citations
9.
Li, Chao, Xi Guo, Huihui Zhang, et al.. (2020). Development and validation of a predictive nomogram for the risk of recurrence in patients with cystitis glandularis. Annals of Translational Medicine. 8(6). 352–352. 8 indexed citations
10.
Hu, Jiao, Huihuang Li, Hao Deng, et al.. (2020). A nomogram incorporating PD-L1, NLR, and clinicopathologic features to predict inguinal lymph node metastasis in penile squamous cell carcinoma. Urologic Oncology Seminars and Original Investigations. 38(7). 641.e19–641.e29. 13 indexed citations
11.
Chen, Jinbo, Huihuang Li, Hao Deng, et al.. (2020). A preoperative nomogram predicting the pseudocapsule status in localized renal cell carcinoma. Translational Andrology and Urology. 9(2). 462–472. 5 indexed citations
12.
Zhou, Xu, Yu Cui, Jinbo Chen, et al.. (2019). UCA1 promotes cell viability, proliferation and migration potential through UCA1/miR-204/CCND2 pathway in primary cystitis glandularis cells. Biomedicine & Pharmacotherapy. 114. 108872–108872. 10 indexed citations
13.
Hu, Jiao, Yu Cui, Peihua Liu, et al.. (2019). <p>Predictors of inguinal lymph node metastasis in penile cancer patients: a meta-analysis of retrospective studies</p>. Cancer Management and Research. Volume 11. 6425–6441. 19 indexed citations
14.
Ren, Wenbiao, et al.. (2019). Prognostic factors for the survival of patients with papillary renal cell carcinoma after surgical management. Clinical & Translational Oncology. 22(5). 725–733. 8 indexed citations
15.
Ren, Wenbiao, et al.. (2019). Low Expression of ATM Indicates a Poor Prognosis in Clear Cell Renal Cell Carcinoma. Clinical Genitourinary Cancer. 17(3). e433–e439. 5 indexed citations
16.
Chen, Jinbo, Meng Zhang, Yu Cui, et al.. (2018). Association Between 12 Polymorphisms of VEGF/Hypoxia/Angiogenesis Pathway Genes and Risk of Urogenital Carcinomas: A Meta-Analysis Based on Case-Control Studies. Frontiers in Physiology. 9. 715–715. 5 indexed citations
17.
Hu, Jiao, Yu Cui, Wenbiao Ren, et al.. (2018). Association of metformin intake with bladder cancer risk and oncologic outcomes in type 2 diabetes mellitus patients. Medicine. 97(30). e11596–e11596. 40 indexed citations
18.
Wen, Shuguang, Wenbiao Ren, Fan Yi, et al.. (2018). Prognostic factors in patients with penile cancer after surgical management. World Journal of Urology. 36(3). 435–440. 33 indexed citations
19.
Ren, Wenbiao, et al.. (2018). Localized chromophobe renal cell carcinoma: preoperative imaging judgment and laparoscopic simple enucleation for treatment. International braz j urol. 44(5). 922–932. 4 indexed citations
20.
Li, Chao, Yu Cui, Longfei Liu, et al.. (2017). High Expression of Long Noncoding RNA MALAT1 Indicates a Poor Prognosis and Promotes Clinical Progression and Metastasis in Bladder Cancer. Clinical Genitourinary Cancer. 15(5). 570–576. 60 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026